Strategic Growth Programme (SGP)

Homegrown Mooring Solutions Provider Mooreast Holdings IPOs on SGX Catalist

Homegrown Mooring Solutions Provider, Mooreast Holdings Ltd., to Raise Total Gross Proceeds of S$8.5M from SGX Catalist IPO Offering of 800,000 Offer Shares at S$0.22 each and Placement of 38,050,000 Placement Shares at S$0.22 each Mooreast has received pre-IPO funding from Singapore-based global investor EDBI IPO Proceeds to fund Mooreast’s growth strategies to become a …

Homegrown Mooring Solutions Provider Mooreast Holdings IPOs on SGX Catalist Read More »

Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings

SINGAPORE, May 26, 2021 – Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, a reputable, long-term institutional investor, and other sophisticated investors.